A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Avacopan D8 | CAS 2316781-77-6 - Request Quote

Picture of Avacopan D8
SZ CAT No:SZ-A174D01
CAS No
2316781-77-6
Mol.F.
C33H27D8F4N3O2
Mol.Wt.
589.7
Inv. Status
Synthesis on demand

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Avacopan D8 is chemically (2R,3S)-2-(4-((cyclopentyl-2,2,3,3,4,4,5,5-d8)amino)phenyl)-1-(2-fluoro-6-methylbenzoyl)-N-(4-methyl-3-(trifluoromethyl)phenyl)piperidine-3-carboxamide. Avacopan D8 is supplied with detailed characterization data compliant with regulatory guideline. Avacopan D8 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Avacopan.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 2316781-77-6

Purchase 2316781-77-6

Order 2316781-77-6

Enquire 2316781-77-6

price of 2316781-77-6

2316781-77-6 Supplier

2316781-77-6 Manufacturer

2316781-77-6 Exporter

buy high quality Avacopan D8

Purchase Avacopan D8

Avacopan D8 suppliers

Avacopan D8 manufacturers

Avacopan D8 price

Order Avacopan D8

Enquire Avacopan D8

Avacopan D8 cost

Avacopan D8 Supplier

Avacopan D8 Distributor

Avacopan D8 for Method Validation

Avacopan Reference Standard

Avacopan D8 for ANDA Filing

Avacopan D8 for Forced Degradation Studies

Avacopan D8 Identification Standards

Avacopan D8 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,